Dans un rapport d'analyse comparative de la qualité, Biopharma distingue Quintiles en tant que leader parmi les grands organismes de recherche clinique pour la fidélité de sa clientèle

RESEARCH TRIANGLE PARK, Caroline du Nord - Mercredi 22 Mai 2013 [ME NewsWire]

(BUSINESS WIRE)--Quintiles est le leader du secteur qui se distingue le plus par la qualité de ses services en recherche clinique de phase II/III, selon 157 professionnels des industries pharmaceutique et biotechnologique ayant répondu au Rapport 2013 d'analyse comparative de la qualité CRO – Phase II/III, intitulé2013 CRO Quality Benchmarking Report – Phase II/III de l'ISR (Industry Standard Research). Les répondants ont également classé Quintiles au rang de leader parmi les grands organismes de recherche clinique pour la fidélité de sa clientèle, définie par la satisfaction globale, la volonté de recommander Quintil ... Read more »

 - Tuesday, May 21st 2013 [ME NewsWire]

(BUSINESS WIRE)-- Please join Dr. Robert Shapiro for a teleconference as he releases a new report on the failure of two Saudi Arabian conglomerates, the Saad Group and the Algosaibi Group, and the management of their debt defaults and restructurings. Dr. Shapiro will assess a number of questions raised about the Saudi Government’s handling of the restructuring process and the impact on Islamic finance and the Saudi business climate.
                        

WHO:
                      

Dr. Robert Shapiro, Chairman of Sonecon, an economic analysis and advisory firm, an advisor to the IMF, and former Under Secretary of Commerce for Economic Affairs in the Clinton administration.
                     ... Read more »

PHILADELPHIA - Tuesday, May 21st 2013 [ME NewsWire]

    Tiotropium delivered by the Respimat® SoftMistTM Inhaler increases time to first severe exacerbation and first episode of asthma worsening across a broad spectrum of patients who remain symptomatic despite at least ICS/LABA therapy
    The improvements in lung function with tiotropium were specific to asthma patients; as a co-morbid condition, chronic obstructive pulmonary disease (COPD) was excluded in this trial

(BUSINESS WIRE)-- For Media outside the U.S., Canada and UK

In patients with symptomatic asthma despite at least ICS/LABA therapy, tiotropium delivered by the Respimat® SoftMistTM Inhaler increases time to first severe exacerbation and first episode of asthma worsening. This improvement is independent of age, allergic status, smoking status and bronchodilator response.1

This was the main finding from pre-planned subgroup analyses of data from the PrimoT ... Read more »

FARMINGTON HILLS, Michigan - Mardi 21 Mai 2013 [ME NewsWire]

(BUSINESS WIRE)--Hilco Industrial, prestataire international de ventes aux enchères de machines et d'équipement industriels va procéder à une vente de plus de 500 lots de matériel de traitement de fruits de mer ayant appartenu à une très grande entreprise de fruits de mer. Le matériel se trouve dans un établissement de traitement ultramoderne et récemment rénové de 23 226 mètres carrés situé à Adak en Alaska.

Le matériel offert comprend neuf chaînes de tri de poissons munies de convoyeurs, de trieurs et de réservoirs d'une capacité de 132 m3. Dix-neuf chaînes de transformation de la goberge comprennent également plusieurs machines automatiques. De nombreuses chaînes de transformation du crabe sont également disponibles, qui comprennent des stations Giller, des cuisinières, des réfrigérateurs, de ... Read more »

Revolutionary multimode M2M technology enables industries to upgrade from legacy copper line systems to secure wireless connectivity

LAS VEGAS - Tuesday, May 21st 2013 [ME NewsWire]

(BUSINESS WIRE)-- Regulatory News:

CTIA Wireless - Gemalto (Euronext NL0000400653 GTO), the world leader in digital security, announces its Cinterion® M2M technology will provide wireless connectivity for Encore Networks’ routers deployed in mission critical applications for diverse market segments from Government, Electrical, Oil & Gas, Waste & Water, Transportation and Enterprise. Developed by Encore Networks, an industrial M2M solutions leader, its routers use Gemalto’s award-winning Cinterion® multimode M2M solution that enables industries to wirelessly gather mission critical data from legacy customer premise equipment and rapidly transmit it to centers around the country.

The Encore Networks ruggedized routers provides cellular IP connectivity using Gemalto ... Read more »

Renewed focus on its core business of developing and operating business parks

Dubai, United Arab Emirates - Tuesday, May 21st 2013 [ME NewsWire]

TECOM Investments, a wholly-owned subsidiary of Dubai Holding, has today announced a new operational structure, which will allow the company to further focus on its core business of developing and operating business parks.

The implementation of a new structure comes at a time when the region’s macroeconomic fundamentals are increasingly positive, offering an opportunity for TECOM Investments to ensure it is strongly positioned to capitalise on Dubai’s future growth prospects.

Under the new structure, TECOM Investments real estate business will be segmented into three verticals. These will be:

    TECOM Development & Planning (Land, Infrastructure and Building Development)
    TECOM Freezone Business Parks
    Dubai Industrial City

Commenting on the ... Read more »

FARMINGTON HILLS, Mich. - Tuesday, May 21st 2013 [ME NewsWire]

(BUSINESS WIRE)-- Hilco Industrial, a world leader in industrial machinery and equipment auctions, will conduct the sale of over 500 lots of seafood processing equipment formerly owned by a very large seafood company. The equipment is located in a recently updated 250,000 sq. ft. state-of-the-art processing facility in Adak, Alaska.

The equipment offered features nine fish sorting lines with conveyors, sorters and 35,000-gallon holding tanks. Nineteen pollock lines also include several heading machines. Multiple crab lines are also available, which include giller stations, cookers, coolers, dip glaze tanks, chillers and an ice flake machine. A cod liver oil processing line, other heading machines, freezers, mixers and generators will also be available.

The auction will take place at the Hilton Garden Inn in Anchorage, Alaska on Tuesday, June 18, 2013, beginning at 10:00 AM HADT. Interested parties can b ... Read more »

L’excellence dans le lancement de nouveaux médicaments permet de réduire les délais de mise sur le marché et de générer des ventes supplémentaires.

LONDRES - Mardi 21 Mai 2013 [ME NewsWire]

(BUSINESS WIRE)--Après des années de faible productivité, la R&D des laboratoires pharmaceutiques et des entreprises de biotechnologies commence enfin à tenir ses promesses. Le nombre de nouvelles molécules approuvées par la FDA (Agence américaine des produits alimentaires et médicamenteux) est reparti à la hausse, tout comme les cours de bourse des entreprises de biotechnologies, signe de la rentabilité de leurs business models. C’est donc maintenant que la stratégie de lancement des nouveaux médicaments prend toute son importance. Le dernier article d'Arthur D. Little (ADL), « Launch excellence for new medicines » (L'excellence dans le lancement de nouveaux médic ... Read more »

Launch excellence can shorten time-to-market and deliver additional sales

LONDON - Tuesday, May 21st 2013 [ME NewsWire]

(BUSINESS WIRE)-- After years of low productivity, R&D in leading pharmaceutical and biotech companies is starting to deliver on its promises; the number of New Molecular Entities (NMEs) approved by the US FDA has leveled out and biotech companies’ share prices are rising, indicating profitable business models. Now is the time for launch. Arthur D. Little’s (ADL) latest viewpoint, ‘Launch excellence for new medicines,’ assesses the key success factors for the successful launch of new medicines.

According to ADL’s most recent project experience, launch excellence has the power to shorten time-to-market by four to six months and it can deliver additional incremental annual sales of up to €50m. In the past, it seemed natural for big pharma companies to launch NMEs in known business areas and territories. However, due to global market access ... Read more »

L’excellence dans le lancement de nouveaux médicaments permet de réduire les délais de mise sur le marché et de générer des ventes supplémentaires.

LONDRES - Mardi 21 Mai 2013 [ME NewsWire]

(BUSINESS WIRE)--Après des années de faible productivité, la R&D des laboratoires pharmaceutiques et des entreprises de biotechnologies commence enfin à tenir ses promesses. Le nombre de nouvelles molécules approuvées par la FDA (Agence américaine des produits alimentaires et médicamenteux) est reparti à la hausse, tout comme les cours de bourse des entreprises de biotechnologies, signe de la rentabilité de leurs business models. C’est donc maintenant que la stratégie de lancement des nouveaux médicaments prend toute son importance. Le dernier article d'Arthur D. Little (ADL), « Launch excellence for new medicines » (L'excellence dans le lancement de nouveaux médic ... Read more »